2018 Mar 1;314(3):H580-H592
A systematic review and meta-analysis of 12 randomized controlled trials (RCTs) involving 11 459 overweight or obese adults without diabetes demonstrated that GLP-1 receptor agonists significantly reduced body weight, alongside notable improvements in glycemic control, lipid levels, and blood pressure
Choosing between two market-leading treatments often comes down to a single, unspoken question: will this medication allow me to live my life, or will I spend my week managing a checklist of discomfort
GHK-Cu is a naturally occurring copper-binding peptide studied for its role in cellular signaling pathways related to tissue support, extracellular matrix biology, and gene expression
This leads to oxidative stress, mitochondrial dysfunction, and cellular imbalance, which in turn contribute to fatigue, cognitive decline, and faster aging